The stock of Ocugen Inc (OCGN) has gone up by 3.91% for the week, with a -11.92% drop in the past month and a 151.99% rise in the past quarter. The volatility ratio for the week is 9.95%, and the volatility levels for the past 30 days are 11.79% for OCGN. The simple moving average for the past 20 days is -9.62% for OCGN’s stock, with a 94.87% simple moving average for the past 200 days.
Is It Worth Investing in Ocugen Inc (NASDAQ: OCGN) Right Now?
The stock has a 36-month beta value of 3.58. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OCGN is 251.68M, and at present, short sellers hold a 17.97% of that float. On May 06, 2024, the average trading volume of OCGN was 9.76M shares.
OCGN) stock’s latest price update
The stock price of Ocugen Inc (NASDAQ: OCGN) has surged by 0.76 when compared to previous closing price of 1.32, but the company has seen a 3.91% gain in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-05-03 that MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that it will host a conference call and live webcast to discuss the Company’s first quarter 2024 financial results and provide a business update at 8:30 a.m. ET on Tuesday, May 14, 2024.
Analysts’ Opinion of OCGN
Many brokerage firms have already submitted their reports for OCGN stocks, with Chardan Capital Markets repeating the rating for OCGN by listing it as a “Buy.” The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $3.50 based on the research report published on March 01, 2023 of the previous year 2023.
Mizuho, on the other hand, stated in their research note that they expect to see OCGN reach a price target of $5. The rating they have provided for OCGN stocks is “Buy” according to the report published on August 23rd, 2022.
ROTH Capital gave a rating of “Buy” to OCGN, setting the target price at $8 in the report published on June 15th of the previous year.
OCGN Trading at 2.48% from the 50-Day Moving Average
After a stumble in the market that brought OCGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.82% of loss for the given period.
Volatility was left at 11.79%, however, over the last 30 days, the volatility rate increased by 9.95%, as shares sank -27.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +33.45% upper at present.
During the last 5 trading sessions, OCGN rose by +3.91%, which changed the moving average for the period of 200-days by +121.48% in comparison to the 20-day moving average, which settled at $1.4465. In addition, Ocugen Inc saw 131.30% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OCGN starting from Zhang Junge, who purchase 200,278 shares at the price of $0.50 back on Jun 14 ’23. After this action, Zhang Junge now owns 1,077,182 shares of Ocugen Inc, valued at $99,999 using the latest closing price.
Stock Fundamentals for OCGN
Current profitability levels for the company are sitting at:
- -10.86 for the present operating margin
- 0.84 for the gross margin
The net margin for Ocugen Inc stands at -10.24. The total capital return value is set at -1.38. Equity return is now at value -103.61, with -74.16 for asset returns.
Based on Ocugen Inc (OCGN), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -8.94. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is 52.3.
Currently, EBITDA for the company is -64.83 million with net debt to EBITDA at 0.5. When we switch over and look at the enterprise to sales, we see a ratio of 51.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.51.
Conclusion
To sum up, Ocugen Inc (OCGN) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
